Viral Load

Displaying 1 - 6 of 6CSV
Brenner, I. R., Flanagan, C. F., Penazzato, M., Webb, K. A., Horsfall, S. B., Hyle, E. P., Abrams, E., Bacha, J., Neilan, A. M., Collins, I. J., Desmonde, S., Crichton, S., Davies, M.-A., Freedberg, K. A., & Ciaranello, A. L. (2024). Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis. The Lancet Global Health, 12(12), e2068–e2079. https://doi.org/10.1016/s2214-109x(24)00381-4
Publication Date
Bakoyannis, G., Elul, B., Wools-Kaloustian, K. K., Brown, S., Semeere, A., Castelnuovo, B., Diero, L., Nakigozi, G., Lyamuya, R., & Yiannoutsos, C. T. (2024). Modeling the HIV cascade of care using routinely collected clinical data to guide programmatic interventions and policy decisions. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000003413
Publication Date
Columbia Affiliation
Fisher, L. H., Kee, J. J., Liu, A., Espinosa, C. M., Randhawa, A. K., Ludwig, J., Magaret, C. A., Robinson, S. T., Gilbert, P. B., Hyrien, O., Kublin, J. G., Rouphael, N., Falsey, A. R., Sobieszczyk, M. E., El Sahly, H. M., Grinsztejn, B., Gray, G. E., Kotloff, K. L., Gay, C. L., … Leathers, V. (2024). SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals. JAMA Network Open, 7(5), e2412835. https://doi.org/10.1001/jamanetworkopen.2024.12835
Publication Date
Smith-Jeffcoat, S. E., Biddle, J. E., Talbot, H. K., Morrissey, K. G., Stockwell, M. S., Maldonado, Y., McLean, H. Q., Ellingson, K. D., Bowman, N. M., Asturias, E., Mellis, A. M., Johnson, S., Kirking, H. L., Rolfes, M. A. R., Olivo, V., Merrill, L., Battan-Wraith, S., Sano, E., McLaren, S. H., … Salvatore, P. P. (2023). Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated Individuals. Clinical Infectious Diseases, 78(5), 1175–1184. https://doi.org/10.1093/cid/ciad696
Publication Date
McLaren, P. J., Porreca, I., Iaconis, G., Mok, H. P., Mukhopadhyay, S., Karakoc, E., Cristinelli, S., Pomilla, C., Bartha, I., Thorball, C. W., Tough, R. H., Angelino, P., Kiar, C. S., Carstensen, T., Fatumo, S., Porter, T., Jarvis, I., Skarnes, W. C., Bassett, A., … Fellay, J. (2023). Africa-specific human genetic variation near CHD1L associates with HIV-1 load. Nature, 620(7976), 1025–1030. https://doi.org/10.1038/s41586-023-06370-4
Publication Date
Columbia Affiliation
Gaebler, C., Nogueira, L., Stoffel, E., Oliveira, T. Y., Breton, G., Millard, K. G., Turroja, M., Butler, A., Ramos, V., Seaman, M. S., Reeves, J. D., Petroupoulos, C. J., Shimeliovich, I., Gazumyan, A., Jiang, C. S., Jilg, N., Scheid, J. F., Gandhi, R., Walker, B. D., … Nussenzweig, M. C. (2022). Prolonged viral suppression with anti-HIV-1 antibody therapy. Nature, 606(7913), 368–374. https://doi.org/10.1038/s41586-022-04597-1
Publication Date